Computational-based drug repurposing methods in COVID-19

COVID-19, as a newly emerging disease, has disrupted human’s different activities. Hence, it is essential to develop drugs or vaccines in order to control COVID-19. Since there is not a medication or vaccine for treating the disease and drug development project is a time and cost consuming process,...

Full description

Bibliographic Details
Main Author:	Yosef Masoudi-Sobhanzadeh
Format:	Article
Language:	English
Published:	Tabriz University of Medical Sciences 2020-07-01
Series:	BioImpacts
Subjects:	covid-19 drug repositioning in silico drug discovery
Online Access:	https://bi.tbzmed.ac.ir/PDF/bi-10-205.pdf

id	doaj-3fcf0318c5804336b45b35a470b7e7fa
record_format	Article
spelling	doaj-3fcf0318c5804336b45b35a470b7e7fa2021-06-22T04:09:42ZengTabriz University of Medical SciencesBioImpacts2228-56602228-56522020-07-0110320520610.34172/bi.2020.25bi-22175Computational-based drug repurposing methods in COVID-19Yosef Masoudi-Sobhanzadeh0Laboratory of Systems Biology and Bioinformatics (LBB), Institute of Biochemistry and Biophysics, University of Tehran, Tehran, IranCOVID-19, as a newly emerging disease, has disrupted human’s different activities. Hence, it is essential to develop drugs or vaccines in order to control COVID-19. Since there is not a medication or vaccine for treating the disease and drug development project is a time and cost consuming process, drug repurposing approaches may yield to proper curing plans. However, there are some limitations in this field, which make the process a challenging one. This letter aims to introduce drug repurposing methods and the existing challenges to detect candidate drugs which may be helpful in controlling COVID-19.https://bi.tbzmed.ac.ir/PDF/bi-10-205.pdfcovid-19drug repositioningin silico drug discovery
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Yosef Masoudi-Sobhanzadeh
spellingShingle	Yosef Masoudi-Sobhanzadeh Computational-based drug repurposing methods in COVID-19 BioImpacts covid-19 drug repositioning in silico drug discovery
author_facet	Yosef Masoudi-Sobhanzadeh
author_sort	Yosef Masoudi-Sobhanzadeh
title	Computational-based drug repurposing methods in COVID-19
title_short	Computational-based drug repurposing methods in COVID-19
title_full	Computational-based drug repurposing methods in COVID-19
title_fullStr	Computational-based drug repurposing methods in COVID-19
title_full_unstemmed	Computational-based drug repurposing methods in COVID-19
title_sort	computational-based drug repurposing methods in covid-19
publisher	Tabriz University of Medical Sciences
series	BioImpacts
issn	2228-5660 2228-5652
publishDate	2020-07-01
description	COVID-19, as a newly emerging disease, has disrupted human’s different activities. Hence, it is essential to develop drugs or vaccines in order to control COVID-19. Since there is not a medication or vaccine for treating the disease and drug development project is a time and cost consuming process, drug repurposing approaches may yield to proper curing plans. However, there are some limitations in this field, which make the process a challenging one. This letter aims to introduce drug repurposing methods and the existing challenges to detect candidate drugs which may be helpful in controlling COVID-19.
topic	covid-19 drug repositioning in silico drug discovery
url	https://bi.tbzmed.ac.ir/PDF/bi-10-205.pdf
work_keys_str_mv	AT yosefmasoudisobhanzadeh computationalbaseddrugrepurposingmethodsincovid19
_version_	1721363785622487040

Computational-based drug repurposing methods in COVID-19

Similar Items